Multiple infliximab biosimilar switches appear to be safe and effective in a real-world inflammatory bowel disease cohort

Beatriz Gros*, Nikolas Plevris, Nathan Constantine-Cooke, Mathew Lyons, Claire O'Hare, Colin Noble, Ian D Arnott, Gareth-Rhys Jones, Charlie W Lees, Lauranne A A P Derikx

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Filter
Active

Search results